Target intelligence / Profile preview

WD repeat-containing protein 3 (WDR3)

Target
WDR3
Molecular classification
Other, WD repeat domain protein, Scaffold protein
01

Overview

WD repeat-containing protein 3 (WDR3) is a nuclear protein characterized by 10 WD repeats—structural motifs of approximately 30–40 amino acids ending in a tryptophan-aspartic acid (W-D) pair[1][3][4][5]. As a member of the WD repeat protein family, WDR3 acts as a scaffold or platform for protein-protein interactions in crucial complexes, particularly in the assembly of the small subunit (SSU) processome involved in ribosome biogenesis[1][3][4][5]. Its core cellular roles include rRNA processing, control of the cell cycle, and participation in functions such as signal transduction and gene regulation[1][3][4]. Although not a classic therapeutic target such as a receptor or enzyme, WDR3 has been described in cancer biology, where it integrates ribosomal biogenesis with the p53 pathway influencing cancer cell proliferation[7]. There are no known direct drugs, biomarkers, or established safety concerns for this molecule as a therapeutic target.

Other names
WD repeat domain 3WDR3FLJ12796UTP12DIP2dJ776P7.2WD repeat-containing protein 3-likeWD repeat domain 3 (wdr3)WD repeat domain 3 S homeolog (wdr3.S)AW546279D030020G18RikMGC76073sb:cb42wu:fb92b07
02

Biological functions

rRNA processingRibosome biogenesisAssembly of small ribosomal subunitCell cycle progressionSignal transductionApoptosisGene regulation
03

Disease associations

Cancer (notably involvement in cancer cell proliferation and p53 pathway integration)Other (possible involvement in genetic diseases due to roles in ribosome biogenesis and cell proliferation)

Beyond the preview

Go deeper on WD repeat-containing protein 3 (WDR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat-containing protein 3 (WDR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call